DK1803441T3 - Farmaceutiske fenofibrat-formuleringer, der har forbedret biotilgængelighed - Google Patents

Farmaceutiske fenofibrat-formuleringer, der har forbedret biotilgængelighed

Info

Publication number
DK1803441T3
DK1803441T3 DK05258082T DK05258082T DK1803441T3 DK 1803441 T3 DK1803441 T3 DK 1803441T3 DK 05258082 T DK05258082 T DK 05258082T DK 05258082 T DK05258082 T DK 05258082T DK 1803441 T3 DK1803441 T3 DK 1803441T3
Authority
DK
Denmark
Prior art keywords
improved bioavailability
fenofibrate formulations
pharmaceutical
fenofibrate
pharmaceutical fenofibrate
Prior art date
Application number
DK05258082T
Other languages
Danish (da)
English (en)
Inventor
Itzhak E Lerner
Vered Rosenberger
Moshe Flashner-Barak
Anna Drabkin
Naomi Moldavski
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of DK1803441T3 publication Critical patent/DK1803441T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK05258082T 2005-12-28 2005-12-28 Farmaceutiske fenofibrat-formuleringer, der har forbedret biotilgængelighed DK1803441T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05258082A EP1803441B1 (fr) 2005-12-28 2005-12-28 Formulation pharmaceutique comprenant du fénofibrate ayant une biodisponibilité ameliorée

Publications (1)

Publication Number Publication Date
DK1803441T3 true DK1803441T3 (da) 2009-08-03

Family

ID=36260529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05258082T DK1803441T3 (da) 2005-12-28 2005-12-28 Farmaceutiske fenofibrat-formuleringer, der har forbedret biotilgængelighed

Country Status (8)

Country Link
EP (1) EP1803441B1 (fr)
AT (1) ATE429902T1 (fr)
DE (1) DE602005014258D1 (fr)
DK (1) DK1803441T3 (fr)
ES (1) ES2325450T3 (fr)
HK (1) HK1104790A1 (fr)
PL (1) PL1803441T3 (fr)
PT (1) PT1803441E (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2730231B1 (fr) 1995-02-02 1997-04-04 Fournier Sca Lab Association de fenofibrate et de vitamine e, utilisation en therapeutique
FR2737121B1 (fr) 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6368622B2 (en) * 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
WO2002024169A1 (fr) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Procede de sechage par atomisation et compositions de fenofibrate
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
EP2085073A1 (fr) 2002-03-26 2009-08-05 Teva Pharmaceutical Industries Ltd. Microparticules de médicament
EP1680091B1 (fr) * 2003-10-10 2017-05-31 Veloxis Pharmaceuticals A/S Forme de dose solide comprenant un fibrate

Also Published As

Publication number Publication date
EP1803441A1 (fr) 2007-07-04
ES2325450T3 (es) 2009-09-04
PT1803441E (pt) 2009-06-08
HK1104790A1 (en) 2008-01-25
ATE429902T1 (de) 2009-05-15
DE602005014258D1 (de) 2009-06-10
PL1803441T3 (pl) 2009-10-30
EP1803441B1 (fr) 2009-04-29

Similar Documents

Publication Publication Date Title
ES2525410T3 (es) Composiciones y métodos para el tratamiento de enfermedades hiperproliferativas dérmicas
DK2415484T3 (da) Sammensætning indeholdende saib til vedvarende lokalbedøvelse
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
CO6150138A2 (es) Ciclobuten-1,2-dionas 3,4-di-sustituidas como ligandos de receptores de quimiocinas cxc
CY1119407T1 (el) Διαμορφωτες toy lxr
CO6362017A2 (es) Peptidos antivirales terapeuticos
WO2006128692A3 (fr) Derives de 2-oxo-1-pyrrolidine
DE602005010788D1 (de) Pharmazeutische Zusammensetzungen zur sicheren Verabreichung von bei der Behandlung von Drogenabhängigkeit verwendeten Arzneimitteln
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
TW200800967A (en) Benzimidazole thiophene compounds
FR2983409B1 (fr) Comprime susceptible de lutter contre le detournement par voie injectable
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
ECSP066564A (es) Formulaciones de tableta de liberación extendida de venlafaxina
DK1729732T3 (da) Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere
BRPI0410044A (pt) forma de dosagem contendo pantoprazol como ingrediente ativo
BRPI0520821A2 (pt) formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada
HRP20080422T3 (en) Satraplatin for treating resistant or refractory tumors
UY29561A1 (es) Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
DK1803441T3 (da) Farmaceutiske fenofibrat-formuleringer, der har forbedret biotilgængelighed
CL2008000949A1 (es) Compuestos derivados de 2,3-benzodiazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos psicoticos.
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents